NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 148 filers reported holding NOVAVAX INC in Q4 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | -100.0% | 88 | -99.9% | 0.00% | -100.0% |
| Q4 2018 | $271,000 | +594.9% | 147,128 | +604.8% | 0.01% | +550.0% |
| Q3 2018 | $39,000 | -78.3% | 20,875 | -84.5% | 0.00% | -77.8% |
| Q2 2018 | $180,000 | -23.7% | 134,279 | +19.7% | 0.01% | -35.7% |
| Q1 2018 | $236,000 | +353.8% | 112,215 | +350.7% | 0.01% | +366.7% |
| Q3 2016 | $52,000 | -81.8% | 24,900 | -55.1% | 0.00% | -81.2% |
| Q1 2016 | $286,000 | +1091.7% | 55,482 | +1860.5% | 0.02% | +1500.0% |
| Q4 2015 | $24,000 | -94.3% | 2,830 | -95.3% | 0.00% | -95.2% |
| Q3 2015 | $423,000 | +4.4% | 59,831 | +22.2% | 0.02% | +5.0% |
| Q1 2015 | $405,000 | +48.4% | 48,972 | -25.3% | 0.02% | +17.6% |
| Q3 2014 | $273,000 | – | 65,515 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |